You are here

P&T News

May 24

Little is known about potential health risks
Product offers first combination of SGLT2 inhibitor and metformin
Cell-based vaccine is successor to trivalent Flucelvax
If approved, the product would be marketed by Merck

May 23

Entresto and Corlanor added to list of treatments
National Eye Institute report identifies trends by race, ethnicity, and gender
Decellularized vascular grafts will be studied in dialysis patients with ESRD
Combination product consists of Tresiba and Victoza

May 20

Generic companies aren’t required to update safety labeling
Company revises tens of thousands of analyses
SGLT2 inhibitor is available as Invokana and Invokamet
New sensor technology could be in clinics next year
Diazepam spray doesn’t measure up to rectal gel

May 19

Doctors’ errors kill hundreds of thousands of people in U.S. each year
Worldwide death toll could reach 10 million by 2050, report warns
First PD-L1 inhibitor to garner agency approval
Product is first myeloma-targeted monoclonal antibody approved in U.S.
Results expected in 2020